Medical Therapy for Benign Prostatic Hyperplasia: New Terminology, New Concepts, Better Choices

Por Kaplan, Steven A
Publicado em 2006

AUA Guidelines and Their Impact on the Management of BPH: An Update

Por Kaplan, Steven A
Publicado em 2004

Factors in Predicting Failure with Medical Therapy for BPH

Por Kaplan, Steven A
Publicado em 2005

The Evolving Role of α-Blockers in Benign Prostatic Hyperplasia and Beyond

Por Kaplan, Steven A
Publicado em 2005

α-Blocker Therapy: Current Update

Por Kaplan, Steven A
Publicado em 2005

Photoselective Vaporization of the Prostate: An Effective Procedure for the Treatment of Benign Prostatic Hyperplasia

Por Kaplan, Steven A
Publicado em 2006

Expanding the Role of Photoselective Vaporization of the Prostate

Por Kaplan, Steven A
Publicado em 2006

Update on the American Urological Association Guidelines for the Treatment of Benign Prostatic Hyperplasia

Por Kaplan, Steven A
Publicado em 2006

Identification of the patient with enlarged prostate: diagnosis and guidelines for management

Por Kaplan, Steven A
Publicado em 2007

Side Effects of α-Blocker Use: Retrograde Ejaculation

Por Kaplan, Steven A
Publicado em 2009

Lower urinary tract symptoms in a 66-year-old man

Por Elterman, Dean S., Kaplan, Steven A.
Publicado em 2014

The Use of Botulinum Toxin in Men with Benign Prostatic Hyperplasia

Por Rusnack, Susan R, Kaplan, Steven A
Publicado em 2005

Phosphodiesterase Type 5 Inhibitors for the Treatment of Male Lower Urinary Tract Symptoms

Por Kaplan, Steven A, Gonzalez, Ricardo R
Publicado em 2007

Optimizing the management of benign prostatic hyperplasia

Por Elterman, Dean S., Barkin, Jack, Kaplan, Steven A.
Publicado em 2012

Testosterone and benign prostatic hyperplasia

Por Jarvis, Thomas R, Chughtai, Bilal, Kaplan, Steven A
Publicado no Asian J Androl (2015)

Laser Prostatectomy: Checkup on the Promises

Por Choi, James, Ikeguchi, Edward F, Te, Alexis E, Kaplan, Steven A
Publicado em 1999

Effect of estimated prostate volume on silodosin-mediated improvements in the signs and symptoms of BPH: does prostate size matter?

Por Kaplan, Steven A, Roehrborn, Claus G, Hill, Lawrence A, Volinn, Weining
Publicado em 2011

Experience with the combination of dutasteride and tamsulosin in the long-term management of benign prostatic hyperplasia

Por Chughtai, Bilal, Elterman, Dean S., Lee, Richard, Te, Alexis E., Kaplan, Steven A.
Publicado em 2012

Long-term Treatment with Finasteride Resulted in a Significant Improvement Relative to Placebo in Clinical Progression of Benign Prostatic Hyperplasia (BPH) in Men with Enlarged Pr...

Por Kaplan, Steven A., Lee, Jeannette Y., Meehan, Alan G., Kusek, John W.
Publicado em 2011

Update on Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia

Por Elterman, Dean S, Chughtai, Bilal, Lee, Richard K, Te, Alexis E, Kaplan, Steven A
Publicado em 2012